SCHEMBL667117

SCHEMBL667117

C/[C]=N/O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL316588 1.00
SCHEMBL454128 1.00
SCHEMBL1498193 0.65
SCHEMBL1666538 0.65
SCHEMBL177760 0.59
SCHEMBL8170052 0.59
SCHEMBL3752303 0.59
SCHEMBL2439268 0.56
SCHEMBL21994500 0.56
SCHEMBL4396694 0.56

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 744 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024053650-A1 COMPOUND HAVING INHIBITORY ACTIVITY AGAINST DIACYLGLYCEROL KINASE α AND/OR ζ, AND PHARMACEUTICAL USE THEREOF 小野薬品工業株式会社 2024-03-14 WO claimed
US-20180153830-A1 SELECTIVE INHIBITORS OF UNDIFFERENTIATED CELLS YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) 2018-06-07 US claimed
US-20170096446-A1 Extended Triterpene Derivatives MYREXIS, INC. (US) 2017-04-06 US claimed
US-20170027890-A1 SELECTIVE INHIBITORS OF UNDIFFERENTIATED CELLS YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) 2017-02-02 US claimed
US-9505800-B2 Extended triterpene derivatives MYREXIS, INC. (US) 2016-11-29 US claimed
US-20150148359-A1 SELECTIVE INHIBITORS OF UNDIFFERENTIATED CELLS YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) 2015-05-28 US claimed
EP-2226322-B1 IMIDAZOLE CARBONYL COMPOUND DAIICHI SANKYO CO LTD (JP) 2015-01-21 EP claimed
US-8927588-B2 Imidazole carbonyl compound DAIICHI SANKYO COMPANY, LIMITED (JP) 2015-01-06 US claimed
US-20140073622-A1 IMIDAZOLE CARBONYL COMPOUND DAIICHI SANKYO COMPANY, LIMITED (JP) 2014-03-13 US claimed
US-8536197-B2 Imidazole carbonyl compound DAIICHI SANKYO COMPANY, LIMITED (JP) 2013-09-17 US claimed
EP-0111146-A2 Anti-mycotic hydroxyalkyl-azolyl derivatives BAYER AG (DE) 1984-06-20 EP claimed
EP-0108995-A1 Hydroxyalkinyl-azolyl derivatives BAYER AG (DE) 1984-05-23 EP claimed
US-4442115-A ANTI-ASTHMA MAY & BAKER LIMITED (GB) 1984-04-10 US claimed
US-4430345-A 6-ALDOXIME OR KETOXIME BICYCLO(2,2,1)-NEPTANES FOR TREATMENT OF THROMBOSIS NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) 1984-02-07 US claimed
EP-0085028-A2 N-Phenylsulfonyl-N'-pyrimidinyl and triazinyl ureas CIBA-GEIGY AG (CH) 1983-08-03 EP claimed
EP-0013607-B1 SUBSTITUTED BICYCLO (2,2,1)HEPTANES AND BICYCLO (2,2,1) HEPT-2-ENES AND THEIR PHARMACEUTICAL COMPOSITIONS NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) 1983-03-23 EP claimed
EP-0018674-A1 Benzodioxincarboxylic acid derivatives, their preparation and their inclusion in lipogenesis inhibiting compositions SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1980-11-12 EP claimed
US-4205076-A Lipogenesis inhibition by certain esters of substituted benzodioxincarboxylic acids SHELL OIL COMPANY (US) 1980-05-27 US claimed
US-4205079-A LIPORENESIS INHIBITORS SHELL OIL COMPANY (US) 1980-05-27 US claimed
US-4202818-A Lipogenesis inhibition by certain esters of substituted benzodioxincarboxylic acids SHELL OIL COMPANY (US) 1980-05-13 US claimed